Good Reads

Scientific literature is growing and becoming overwhelming. Every minute scientific work is pouring in, making it difficult to identify the best from the mediocre and the useful from the trivial.

We at the Board of Education in association with the experts from the Indian Journal of Urology, handpick the right content in Urology for you so that you get the best of scientific advances without wasting precious time from your practice.


Good Reads for February

Classic Articles

  1. Tannock IF, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004;351:1502–12.
  2. Stamey TA, et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909–16
  3. Pound CR, et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281:1591–7
  4. Catalona WJ, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994;151:1283–90
  5. Goldstein I, et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998;338:1397–404
  6. Gleason DF, et al. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58–64
  7. D’Amico AV, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280:969–74
  8. Robson CJ, et al. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969;101:297–301
  9. Bolla M, et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 1997;337:295–300
  10. Mebust WK, et al. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989;141:243–7
  11. Calne RY, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978;2:1323–7
  12. Andriole GL, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009;360:1310–9
  13. Hodge KK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71–4
  14. Walsh, P.C. and Donker, P.J. Impotence following radical prostatectomy: insight into etiology and prevention. J. Urol. 1982; 128: 492
  15. Morales A, et al. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 1976;116:180–3
  16. Bill-Axelson A, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005;352:1977–84
  17. Motzer RJ, et al. Sunitinib in patients with metastatic renal cell carcinoma. JAMA 2006;295:2516–24
  18. Chaussy C, Schmiedt E, Jocham D, Brendel W, Forssmann B, Walther V. First clinical experience with extracorporeally induced destruction of kidney stones by shock waves. J Urol. 1982 Mar;127(3):417-20
  19. Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin. 1972 Jul-Aug;22(4):232-40.
  20. Clayman RV, Kavoussi LR, Soper NJ, Dierks SM, Meretyk S, Darcy MD, Roemer FD, Pingleton ED, Thomson PG, Long SR. Laparoscopic nephrectomy: initial case report.J Urol. 1991 Aug;146(2):278-82.

Latest Articles

  1. Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 2016;375:1415-24.
  1. Yaxley JW, Coughlin GD, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: Early outcomes from a randomised controlled phase 3 study. Lancet 2016;388:1057-66.
  1. Cui T, Kovell RC, Terlecki RP. Is it time to abandon the digital rectal examination? Lessons from the PLCO Cancer Screening Trial and peer-reviewed literature. Curr Med Res Opin 2016;July 4:1-7.(Epub)
  1. Amundsen CL, Richter HE, Menefee SA, Komesu YM, Arya LA, Gregory WT, et al. OnabotulinumtoxinA vs. sacral neuromodulation on refractory urgency urinary incontinence in women: A randomized clinical trial. JAMA 2016;316:1366-74.
  1. Ravaud A, et al. Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy. N Engl J Med. 2016 Dec 8;375(23):2246-2254

____________________________________________________________________________________